Join our daily newsletter At The Bell to receive exclusive market insights
The ASX has been trading flat at around 7,928 points.
Discretionary has been the best-performing sector today, up 1%, followed by Financials, up 0.66%, and Utilities, up 0.5%.
Staples has been the worst performing, down 1%, followed by Materials, down 0.9%, and Industrials, down 0.8%.
Opthea (ASX:OPT) has been the most watched on HotCopper forums today and is in a trading halt. Its COAST Phase 3 trial failed to meet the primary endpoint of mean change in best corrected visual acuity from baseline to Week 52. The company is considering the overall impact of the negative trial result heading into the year.
Also trending: Errawarra Resources (ASX:ERW), which has entered binding agreements to acquire 70% of the historical Elizabeth Hill Silver Project, 70% of the silver rights to the Pinderi Hills Project tenement package, and 70% of the ownership of three tenements surrounding the silver project.
Rounding out the most discussed has been Memphasys (ASX: MEM), which unveiled the successful unblinding and data analysis of its pivotal clinical trial for the Felix System, confirming its best-in-class performance in sperm selection for Assisted Reproductive Technology.
You’re up to date — see you later for Market Close.
More market news
51st State: What is Trump’s endgame with tariffs – and what will it mean for Canada?
Meet GeoGeorge: The HotCopper poster so accurate he got hired as an analyst
Join the discussion: See what’s trending right now on Australia’s largest stock forum and be part of the conversations that move the markets.
The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.
